# FDA 483 - Samsung Biologics Co., Ltd. - September 10, 2019

Source: https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/77f6bf66-c495-4acb-9642-77c572ec02e0

> FDA 483 for Samsung Biologics Co., Ltd. on September 10, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Samsung Biologics Co., Ltd.
- Inspection Date: 2019-09-10
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
- Summary: An FDA inspection of Samsung Biologics Co., Ltd in Incheon, Republic of Korea, a drug substance manufacturer, identified several deficiencies. Observations included inadequate maintenance of utilities and equipment, insufficient written procedures for the transfer of QC materials, and a lack of proper review for employee training. These findings highlight areas requiring improvement in the firm's quality management system.

## Related Documents

- [483 - 2025-05-27](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/b3a6afca-acc1-42d3-9eaa-a9c039d1bb0a)
- [483 - 2022-06-09](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/134cfe7e-fea2-4b96-9e87-ef42c2597d55)
- [483 - 2021-08-24](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/f660cf8a-50b8-4766-b37d-4605324fd16b)
- [483 - 2022-06-09](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/caf2bc64-dcd8-4d80-a40d-ca04258e6266)
- [483 - 2018-06-26](https://www.globalkeysolutions.net/records/483/samsung-biologics-co-ltd/f30ce007-aebc-4adb-b5d0-3fe2fcb25da0)

## Related Officers

- [Philip Angart](https://www.globalkeysolutions.net/people/philip-angart/356242cd-f6f5-4df6-b795-75e0d24b63ef)
- [Marie Gutteriez](https://www.globalkeysolutions.net/people/marie-gutteriez/aeb29231-0a5d-4e9e-b232-73674f4539a4)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/samsung-biologics-co-ltd/817b7bc4-2de1-47f4-b552-178303c8da01

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd